ATE96658T1 - Verfahren zum mikronisieren schwerloeslicher arzneistoffe. - Google Patents

Verfahren zum mikronisieren schwerloeslicher arzneistoffe.

Info

Publication number
ATE96658T1
ATE96658T1 AT90114858T AT90114858T ATE96658T1 AT E96658 T1 ATE96658 T1 AT E96658T1 AT 90114858 T AT90114858 T AT 90114858T AT 90114858 T AT90114858 T AT 90114858T AT E96658 T1 ATE96658 T1 AT E96658T1
Authority
AT
Austria
Prior art keywords
micronizing
medicinal substances
partly soluble
soluble medicinal
drug
Prior art date
Application number
AT90114858T
Other languages
English (en)
Inventor
Masayoshi Samejima
Kazuo Noda
Masao Kobayashi
Takashi Osawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE96658T1 publication Critical patent/ATE96658T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT90114858T 1989-08-04 1990-08-02 Verfahren zum mikronisieren schwerloeslicher arzneistoffe. ATE96658T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1204132A JP2642486B2 (ja) 1989-08-04 1989-08-04 難溶性薬物の超微粒子化法
EP90114858A EP0411629B1 (de) 1989-08-04 1990-08-02 Verfahren zum Mikronisieren schwerlöslicher Arzneistoffe

Publications (1)

Publication Number Publication Date
ATE96658T1 true ATE96658T1 (de) 1993-11-15

Family

ID=16485367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90114858T ATE96658T1 (de) 1989-08-04 1990-08-02 Verfahren zum mikronisieren schwerloeslicher arzneistoffe.

Country Status (9)

Country Link
US (1) US5202129A (de)
EP (1) EP0411629B1 (de)
JP (1) JP2642486B2 (de)
KR (1) KR0126465B1 (de)
AT (1) ATE96658T1 (de)
CA (1) CA2022465C (de)
DE (1) DE69004372T2 (de)
DK (1) DK0411629T3 (de)
ES (1) ES2062221T3 (de)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US7336788B1 (en) * 1992-12-09 2008-02-26 Discovery Communicatoins Inc. Electronic book secure communication with home subsystem
JP3254219B2 (ja) * 1993-01-19 2002-02-04 ワーナー−ランバート・コンパニー 安定な経口用のｃｉ−９８１製剤およびその製法
US20070116761A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6794357B1 (en) * 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US7865567B1 (en) 1993-12-02 2011-01-04 Discovery Patent Holdings, Llc Virtual on-demand electronic book
US6165976A (en) * 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
CA2172807C (en) * 1994-08-01 1999-10-12 Keith S. Lienhop Tastemasked liquid pharmaceutical delivery system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
PT806945E (pt) * 1994-12-22 2003-09-30 Astrazeneca Ab Preparacao terapeutica para inalacao que contem a hormona paratiroide, hpt
WO1996019198A1 (en) 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5503723A (en) * 1995-02-08 1996-04-02 Eastman Kodak Company Isolation of ultra small particles
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
ES2435944T3 (es) * 1997-06-27 2013-12-26 Abraxis Bioscience, Llc Nuevas formulaciones de agentes farmacológicos, métodos para su preparación y métodos para su uso
ZA991922B (en) 1998-03-11 1999-09-13 Smithkline Beecham Corp Novel compositions of eprosartan.
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US8771740B2 (en) 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
JP2003518038A (ja) 1999-12-20 2003-06-03 ニコラス， ジェイ カークホフ， 流動床噴霧乾燥によるナノ粒子製造方法
IL154457A0 (en) * 2000-08-14 2003-09-17 Teva Pharma Mircronized torsemide
EP1339395A2 (de) 2000-11-28 2003-09-03 Fmc Corporation Essbare überzugszusammensetzung aus pga (propylenglykolalginat)
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
CA2450900C (en) * 2001-06-29 2010-08-24 Eurand Pharmaceuticals Limited Drug activation process and vibrational mill therefor
WO2007064311A1 (en) * 2001-07-10 2007-06-07 Teva Pharmaceutical Industries Ltd. Micronized mirtazapine
JP2004537401A (ja) 2001-08-08 2004-12-16 ブラウン ユニバーシティ リサーチ ファウンデーション 疎水性薬物の微粉砕方法
US7011842B1 (en) 2002-06-21 2006-03-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US7794743B2 (en) * 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7033602B1 (en) * 2002-06-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7070798B1 (en) 2002-06-21 2006-07-04 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
US7217426B1 (en) 2002-06-21 2007-05-15 Advanced Cardiovascular Systems, Inc. Coatings containing polycationic peptides for cardiovascular therapy
US7056523B1 (en) 2002-06-21 2006-06-06 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
US6994867B1 (en) 2002-06-21 2006-02-07 Advanced Cardiovascular Systems, Inc. Biocompatible carrier containing L-arginine
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US7094256B1 (en) 2002-12-16 2006-08-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical device containing polycationic peptides
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US20040146537A1 (en) * 2003-01-28 2004-07-29 Ramachandran Radhakrishnan Oily wax matrix suspension formulation comprising pharmacologically active agents
CA2511992A1 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
RS20060009A (sr) * 2003-07-11 2008-06-05 F.Hoffmann-La Roche Ag., Oralni oblik za doziranje sakvinavir mezilata
JP2006528182A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 薬学的製剤および酸に起因する消化器疾患の治療法
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
DK1701698T3 (da) * 2004-01-08 2008-05-05 Wyeth Corp Direkte komprimerbart farmaceutisk præparat til oral indgivelse af CCI-779
CA2582231A1 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Steroid analogs and uses
ES2231043B2 (es) * 2004-10-29 2005-10-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
JP4754211B2 (ja) * 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法
WO2006069419A1 (en) * 2004-12-31 2006-07-06 Iceutica Pty Ltd Nanoparticle composition and methods for synthesis thereof
CN101232905B (zh) * 2005-07-25 2013-01-09 大塚制药株式会社 一种用于测量嘧啶代谢能力的口服制剂
KR101409302B1 (ko) * 2005-08-02 2014-06-20 드로싸팜 아게 인도메타신 및／또는 아세메타신을 포함하는 약학적 조성물
US20070092576A1 (en) * 2005-10-20 2007-04-26 Adolor Corporation Compositions containing opioid antagonists
CA2631492A1 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
JP2009519972A (ja) * 2005-12-15 2009-05-21 アキュスフィア， インコーポレイテッド 粒子ベースの経肺投与または経鼻投与用製薬の製造方法
BRPI0708556A2 (pt) * 2006-03-06 2011-05-31 Teva Pharma composição de ezetimiba
JP2007314529A (ja) * 2006-04-28 2007-12-06 Lion Corp 造粒粒子、錠剤、及び造粒粒子の製造方法
NZ573823A (en) * 2006-06-30 2012-05-25 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
AU2013273795C1 (en) * 2006-06-30 2016-08-18 Iceutica Pty Ltd Method for the Preparation of Biologically Active Compounds in Nanoparticle Form
AU2012203877B2 (en) * 2006-06-30 2013-10-10 Iceutica Pty Ltd Methods For The Preparation Of Biologically Active Compounds In Nanoparticulate Form
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
AU2016203251B2 (en) * 2006-06-30 2017-11-16 Iceutica Pty Ltd Methods for the Preparation of Biologically Active Compounds in Nanoparticle Form
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
ES2644803T5 (es) * 2007-03-29 2024-02-26 Daiichi Sankyo Co Ltd Composición farmacéutica
TWI405590B (zh) 2007-04-06 2013-08-21 活效製藥股份有限公司 微粉碎化有機化合物粒子之製法
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
JP2009091298A (ja) * 2007-10-10 2009-04-30 Asuka Corporation:Kk 皮膚改善化粧料
AU2009211028B2 (en) * 2008-02-06 2013-12-05 Wockhardt Research Centre Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
ATE534382T1 (de) * 2008-02-06 2011-12-15 Wockhardt Ltd Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
US20170105966A1 (en) * 2008-02-28 2017-04-20 Roger Imboden Pharmaceutical composition containing indometacin and/or acemetacin
JP5149673B2 (ja) * 2008-04-03 2013-02-20 有限会社不動権現 こんにゃく粉製造方法
KR101545300B1 (ko) 2008-04-03 2015-08-18 하버 바이오사이언시즈 인코포레이티드 고체 형태의 약제
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
DE102008037025C5 (de) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
MX2011002847A (es) * 2008-09-19 2011-04-07 Activus Pharma Co Ltd Polvo de compuesto organico combinado para uso medico y metodo de produccion y suspension del mismo.
EP2168573A1 (de) * 2008-09-30 2010-03-31 LEK Pharmaceuticals D.D. Zubereitungen enthaltend Ezetimib
EA201171284A1 (ru) * 2009-04-24 2012-05-30 Айсьютика Пти Лтд. Новая технология изготовления напроксена
AU2010239080B2 (en) 2009-04-24 2014-08-28 Iceutica Pty Ltd A novel formulation of diclofenac
AU2010239161B2 (en) * 2009-04-24 2014-10-09 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale
KR101679522B1 (ko) * 2009-04-24 2016-11-24 아이슈티카 피티와이 리미티드 생물학적 활성 물질의 용해 프로파일 개선방법
UA106231C2 (uk) 2009-04-24 2014-08-11 Айсьютика Пти Лтд Разова доза фармацевтичної композиції індометацину (варіанти)
EP2421530B1 (de) * 2009-04-24 2019-08-21 Iceutica Pty Ltd. Metaxalonformulierung
NZ595902A (en) * 2009-04-24 2014-10-31 Iceutica Pty Ltd Method for the production of commercial nanoparticle and microparticle powders
WO2011039952A1 (ja) 2009-09-30 2011-04-07 株式会社サンギ 難溶性物質の水溶解性改善方法
KR101792299B1 (ko) 2010-03-19 2017-10-31 다이이찌 산쿄 가부시키가이샤 항응고제의 용출 개선 방법
CN102858682B (zh) 2010-03-22 2014-07-16 株式会社Bio-Synectics 纳米颗粒制备方法
CN102408756B (zh) * 2011-08-05 2013-06-19 中国人民解放军第四军医大学 DiI 显微颗粒简易制作及其标记神经元的方法
KR101940840B1 (ko) 2011-08-10 2019-01-21 다이이찌 산쿄 가부시키가이샤 디아민 유도체 함유 의약 조성물
KR101794032B1 (ko) 2011-09-21 2017-11-07 (주)바이오시네틱스 나노입자 제조방법
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
KR102105354B1 (ko) 2012-08-20 2020-04-29 오츠카 세이야쿠 가부시키가이샤 당대사능의 측정 방법 및 그에 사용하는 조성물
ES2754246T3 (es) 2013-03-15 2020-04-16 Otsuka Pharma Co Ltd Composición para su uso en un método para medir la razón de combustión azúcar/ácido graso
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
EP3466411A4 (de) * 2016-05-31 2020-01-15 Kyowa Hakko Kirin Co., Ltd. Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit mikropartikeln eines schwer löslichen arzneimittels
EP3453384B1 (de) 2017-09-07 2020-05-27 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmazeutische tablette enhaltend bilastin
ES2835287T3 (es) 2017-12-18 2021-06-22 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
WO2020179025A1 (ja) * 2019-03-06 2020-09-10 株式会社伊藤園 植物含有組成物の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE773113A (fr) * 1970-09-28 1972-01-17 Controlled Medications Composition pharmaceutique a liberation progressive de la substance active
FR2162245A1 (en) * 1971-12-06 1973-07-20 Sobio Lab Micronized l-dopa - with increased bioavailability
DE2401037C2 (de) * 1974-01-10 1978-03-30 Eric G. 7000 Stuttgart Doubleday Rohrstück für Reinigungsmaschinen, insbesondere für Staub- oder Flüssigkeitssauggeräte
FR2257266B1 (de) * 1974-01-10 1977-07-01 Pasteur Institut
JPS5132718A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Nanyoseiyakuhin no yoshutsusokudochosetsuho
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
JPH0215026A (ja) * 1988-07-01 1990-01-18 Takada Seiyaku Kk 新規なプロブコール固形製剤
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules

Also Published As

Publication number Publication date
DK0411629T3 (da) 1993-12-13
EP0411629B1 (de) 1993-11-03
EP0411629A3 (en) 1991-05-08
KR910004183A (ko) 1991-03-28
KR0126465B1 (ko) 1997-12-24
EP0411629A2 (de) 1991-02-06
DE69004372T2 (de) 1994-04-21
US5202129A (en) 1993-04-13
CA2022465A1 (en) 1991-02-05
DE69004372D1 (de) 1993-12-09
JP2642486B2 (ja) 1997-08-20
JPH0366613A (ja) 1991-03-22
CA2022465C (en) 1998-04-21
ES2062221T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
DE69004372D1 (de) Verfahren zum Mikronisieren schwerlöslicher Arzneistoffe.
PT84785B (pt) Processo para a preparacao de composicoes farmceuticas que contem omeprazole para administracao por via oral
ATE119393T1 (de) Verwendung eines opiatantagonisten zur herstellung eines transdermal zu verabreichenden arzneimittels sowie eine vorrichtung zur transdermalen verabreichung.
HU903846D0 (en) Process for producing imidazolyl-alkenic acids and pharmaceutical preparatives containing these compounds as active substance
ZA888734B (en) Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations
YU215090A (sr) Formulacija u obliku pilule za kontrolisano oslobađanje
EP0404283A3 (de) 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
NZ225242A (en) Pad printing process for manufacturing a pharmaceutical presentation and/or dosage form for active ingredients of drugs
HUT51620A (en) Process for producing multicyclic pyrimidine derivatives and pharmaceutical preparations containing these compounds as active substance
BR9304431A (pt) Medicamento processo para sua preparaçao e aplicaçao de uma mistura
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
AU7470287A (en) Pharmaceutical compositions with galactitol as carrier
PT86874A (pt) Process for the preparation of cromona by products and of pharmaceutical compounds containing them
FR2422640A1 (fr) Nouvelles morphinane-6-ones a substituant 8b-alkyle, leur procede de production et medicament les contenant
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
HU906459D0 (en) Process for producing new pyridone derivatives and pharmaceutical preparatives containing them as active substance
PT88634A (pt) A process for the preparation of catechol carboxylic acid derivatives and of pharmaceutical compositions containing the same
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
IL88222A0 (en) Medicaments comprising 2-pyrimidinyl-1-piperazine derivatives
HUT47077A (en) Process for producing hydrocinnamomic acid derivatives and pharmaceutical compositions containing them as active components
EA199800179A1 (ru) Способ изготовления твердых лекарственных форм, содежащих лекарства в очень малых дозах
PT84405B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 2-alcoxi-n-(1-azabiciclo {2.2.2} octil-3-benzamida-n-oxidos apropriadas para controlar a emese provocada por drogas anti-cancro
DE3881254D1 (de) Pharmazeutische zusammensetzung.
HU904062D0 (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds as active substance
HU901875D0 (en) Process for production of galenical preparations providing optimal biological accessibility of 2-hydroxi-5-methyl-laurophenon-oxim as active substance

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee